Abstract
• Background: Endotoxin-induced uveitis (EIU) is a model for acute anterior uveitis associated with a variety of pro-inflammatory cytokines and nitric oxide production. Interleukin 10 (IL-10) down-regulates these inflammatory mediators. We report a study of the effect of systemic administration of IL-10 on the inflammatory parameters of EIU. • Methods: Uveitis was induced in C3H/HeN mice by subcutaneous injection of 200 μg lipopolysaccharide (LPS) per mouse. Intraocular inflammation was assessed by leukocyte count and measurement of the protein concentration in the aqueous humor (AH). Mouse recombinant IL-10 at 1000 U or its vehicle alone were administered by three intravenous injections given 4.0 h and 0.5 h before and 8.0 h after LPS injection. • Results: The inflammatory cell infiltration in the eyes was significantly reduced in four of five experiments from 40% to 64% in the groups treated with IL-10 compared to the control groups (P<0.05). In contrast, the level of protein exudation in the anterior chamber (AC) was not significantly affected by IL-10 treatment. • Conclusion: IL-10 reduces the cellular infiltration in the ocular inflammation produced by endotoxin. This result suggests potential usefulness for IL-10 in the treatment of severe anterior uveitis with a strong cellular component.
Similar content being viewed by others
References
Bogdan C, Vodovotz Y, Nathan C (1991) Macrophage deactivation by interleukin 10. J Exp Med 174:1549–1555
Chesrown SE, Monnier J, Visner G, Nick HS (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun 200: 126–134
Cunha FQ, Moncada S, Liew FY (1992) Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun 182:1155–1159
Delvaux A, Donckier V, Bruyns C, Florquin S, Gerard C, Amaraoui Z, Abramowicz D, Goldman M, Velu T (1994) Effect of systemic administration of rIL-10 in an in vivo model of alloreactivity. Transplantation 58: 972–974
Durez P, Abramovicz C, Gerard C, Van Mechelen M, Amraoui Z, Dubois C, Leo O, Velu T, Goldman M (1993) In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med 177:551–555
Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081–2095
Gerard C, Bruyns C, Marchant A, Abramowicz D, Vandenabeele P, Delvaux A, Fiers W, Goldman M, Velu T (1993) Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177:547–550
Hoekzema R, Verhagen C, Haren M van, Kijlstra A (1992) Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6. Invest Ophthalmol Vis Sci 33:532–539
Guex-Crosier Y, Wittwer AJ, Roberge FG (1996) Intraocular production of a cytokine (CINC) responsible for neutrophil infiltration in endotoxin-induced uveitis. Br J Ophthalmol 80:649–653
Howard M, Muchamuel T, Andrade S, Menon S (1993) Interleukin 10 protects mice from lethan endotoxemia. J Exp Med 177:1205–1208
Kasner L, Chan CC, Whitcup SM, Gery I (1993) The paradoxical effect of tumor necrosis factor alpha (TNF-alpha) in endotoxin-induced uveitis. Invest Ophthalmol Vis sci 34:2911–2917
Li Q, Peng B, Whitcup SM, Sung UJ, Chan C-C (1995) Endotoxin induced uveitis in the mouse: susceptibility and genetic control. Exp Eye Res 61: 629–632
Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y (1994) The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. Invest Ophthalmol Vis Sci 35:3673–3680
Marchant A, Bruyns C, Vandenabeele P, Ducarme M, Gerard C, Delvaux A, De GD, Abramowicz D, Velu T, Goldman M (1994) Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24: 1167–1171
Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56:1–26
Parks DJ, Cheung MK, Chan CC, Roberge FG (1994) The role of nitric oxide in uveitis. Arch Ophthalmol 112:544–546
Planck SR, Huang XN, Robertson JE, Rosenbaum JT (1994) Cytokine mRNA level in rat ocular tissues after systemic endotoxin treatment. Invest Ophthalmol Vis Sci 35:924–930
Randow F, Syrbe U, Meisel C, Krausch D, Zuckermann H, Platzer C, Volk HD (1995) Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med 181: 1887–1892
Tilton RG, Chang K, Corbett JA, Misko TP, Currie MG, Bora NS, Kaplan HJ, Williamson JR (1994) Endotoxin-induced uveitis in the rat is attenuated by inhibition of nitric oxide production [see comments]. Invest Ophthalmol Vis Sci 35:3278–3288
Vos AF de, Haren MAC van, Verhagen C, Hoekzema R, Kijlstra A (1994) Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 35:1100–1106
Waal Malefyt R de, Abrams J, Bennett B, Figdor CG, de VJ (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209–1220
Wang P, Wu P, Anthes JC, Siegel MI, Egan RW Billah MM (1994) Interleukin-10 inhibits interleukin-8 production in human neutrophils. Blood 83:2678–2683
Yoshida M, Yoshimura N, Hangai M, Tanihara H, Honda Y (1994) Interleukin-1 alpha, interleukin-1 beta, and tumor necrosis factor gene expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 35:1107–1113
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hayashi, S., Guex-Crosier, Y., Delvaux, A. et al. Interleukin 10 inhibits inflammatory cells infiltration in endotoxin-induced uveitis. Graefe's Arch Clin Exp Ophthalmol 234, 633–636 (1996). https://doi.org/10.1007/BF00185297
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00185297